OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults
Nelson Lee, Lena Nguyen, Peter C. Austin, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 5, pp. 1372-1382
Open Access | Times Cited: 7
Nelson Lee, Lena Nguyen, Peter C. Austin, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 5, pp. 1372-1382
Open Access | Times Cited: 7
Showing 7 citing articles:
Longitudinal Follow‐Up of the Specific Antibody Response to SARS‐CoV‐2 Vaccination in Colombia
Myriam Arévalo‐Herrera, Bladimiro Rincón‐Orozco, John Mario González‐Escobar, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access
Myriam Arévalo‐Herrera, Bladimiro Rincón‐Orozco, John Mario González‐Escobar, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access
Quantitative observational evidence of indirect herd benefits from COVID-19 vaccination or prior infection on SARS-CoV-2 infections and COVID-19 deaths: a population-based retrospective cohort study in Ontario, Canada
Linwei Wang, Sarah Swayze, Arjumand Siddiqi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Linwei Wang, Sarah Swayze, Arjumand Siddiqi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort study
Felippe Lazar Neto, Matt D. T. Hitchings, Avnika B. Amin, et al.
The Lancet Regional Health - Americas (2024) Vol. 34, pp. 100755-100755
Open Access | Times Cited: 3
Felippe Lazar Neto, Matt D. T. Hitchings, Avnika B. Amin, et al.
The Lancet Regional Health - Americas (2024) Vol. 34, pp. 100755-100755
Open Access | Times Cited: 3
A Systematic Review and Meta-Analysis on the Effectiveness of Bivalent mRNA Booster Vaccines against Omicron Variants
Shangchen Song, Zachary J. Madewell, Ming‐Jin Liu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Shangchen Song, Zachary J. Madewell, Ming‐Jin Liu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Vaccine Effectiveness against GP-Attended Symptomatic COVID-19 and Hybrid Immunity among Adults in Hungary during the 2022–2023 Respiratory Season Dominated by Different SARS-CoV-2 Omicron Subvariants
J Horváth, Gergő Túri, Katalin Krisztalovics, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 496-496
Open Access
J Horváth, Gergő Túri, Katalin Krisztalovics, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 496-496
Open Access
The COVID-19 pandemic in Canada’s provinces: mitigation measures and outcomes
Paul Grootendorst
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Paul Grootendorst
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Limited durability of protection conferred by XBB.1.5 vaccines against Omicron-associated severe outcomes among community-dwelling adults aged ≥50 years, Ontario, Canada, September 2023 to June 2024
Nelson Lee, Lena Nguyen, Sharifa Nasreen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Nelson Lee, Lena Nguyen, Sharifa Nasreen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
